Patent details

EP2187873 Title: ABUSE RESISTANT DRUGS, METHOD OF USE AND METHOD OF MAKING

Basic Information

Publication number:
EP2187873
PCT Application Number:
US2008072914
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087977161
PCT Publication Number:
WO2009023672
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ABUSE RESISTANT DRUGS, METHOD OF USE AND METHOD OF MAKING
French Title of Invention:
MÉDICAMENTS RÉSISTANT AUX ABUS, PROCÉDÉS D'UTILISATION ET DE FABRICATION
German Title of Invention:
GEGEN MISSBRAUCH GESICHERTE ARZNEIMITTEL, ANWENDUNGSVERFAHREN UND HERSTELLUNGSVERFAHREN
SPC Number:

Dates

Filing date:
12/08/2008
Grant date:
25/07/2018
EP Publication Date:
26/05/2010
PCT Publication Date:
19/02/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/07/2018
EP B1 Publication Date:
25/07/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/08/2018
Expiration date:
12/08/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/07/2018
 
 

Name:
Abuse Deterrent Pharmaceutical LLC
Address:
612 Corporate Way, Suite 10, Valley Cottage, NY 10989, United States (US)

Inventor

1

Name:
SHAH, Manish S.
Address:
United States (US)

2

Name:
DIFALCO, Ray J.
Address:
United States (US)

Priority

Priority Number:
955584 P
Priority Date:
13/08/2007
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/16; A61K 9/20; A61K 9/24; A61K 9/28; A61K 9/48; A61K 31/138; A61K 31/437; A61K 31/4458; A61K 31/485;

Publication

European Patent Bulletin

Issue number:
201830
Publication date:
25/07/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
31/12/2018 Outgoing Correspondence 1